[HDL-C/apoA-I]: A multivessel cardiometabolic risk marker in women with T2DM.
Michel P HermansPaul ValensiSylvie A AhnMichel F RousseauPublished in: Diabetes/metabolism research and reviews (2017)
[HDL-C/apoA-I] can stratify T2DM women according to metabolic phenotype, macrovascular and coronary damage, β-cell function, microangiopathic risk, and retinopathy. This ratio is a versatile and readily available marker of cardiometabolic status and vascular complications in T2DM women.
Keyphrases
- polycystic ovary syndrome
- breast cancer risk
- coronary artery disease
- pregnancy outcomes
- glycemic control
- percutaneous coronary intervention
- heart failure
- type diabetes
- coronary artery bypass grafting
- st segment elevation myocardial infarction
- left ventricular
- st elevation myocardial infarction
- pregnant women
- weight loss
- atrial fibrillation
- acute coronary syndrome
- transcatheter aortic valve replacement
- aortic valve
- skeletal muscle
- aortic stenosis
- ejection fraction